A Safety Follow-up Study of a Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Cellgram-ED (Autologous Bone Marrow-Derived Mesenchymal Stem Cells) in Patients With Post-Radical Prostatectomy Erectile Dysfunction
Condition: Erectile Dysfunction
Study Type: Observational
Clinical Trials Identifier NCT 8-digits: NCT07431008
Sponsor: Pharmicell Co., Ltd.
Phase:
Eligibility:
- Age: minimum 19 Years maximum 80 Years
- Gender: Male
Inclusion Criteria:
- Participants who previously participated in the parent clinical trial and received the cell therapy (Cellgram-ED).
- Participants who have provided written informed consent to participate in this safety follow-up study.
Exclusion Criteria:
View trial on ClinicalTrials.gov